U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
PositiveFinancial Markets

- The Trump administration has announced negotiated prices for 15 drugs under Medicare, which could have saved the program $12 billion last year, reducing spending on these medications by 44%. The list includes popular inhalers like Breo Ellipta and treatments for various conditions including cancer and diabetes.
- This development is significant for Medicare as it aims to lower prescription drug costs for beneficiaries, potentially improving access to essential medications and alleviating financial burdens on the healthcare system.
- However, the announcement comes amid rising healthcare costs, with projections indicating that Medicare Part B premiums are set to exceed $200 a month for the first time in 2026, reflecting ongoing challenges in managing healthcare expenses.
— via World Pulse Now AI Editorial System


